AAAAAA

   
Results: 1-25 | 26-50 | 51-66 |
Results: 51-66/66
LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS
Authors: FRASSINETI GL NANNI O MILANDRI C FERRARI M DEMATTEIS A MUSTACCHI G CARIELLO S MASCIA V SANTORO A AMADORI D LOMBARDI A
Citation: Gl. Frassineti et al., LONIDAMINE IN MODULATION OF RESPONSE TO ADRIAMYCIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, International journal of oncology, 4, 1994, pp. 741-746
CLINICAL-PREDICTION OF SURVIVAL IS MORE ACCURATE THAN THE KARNOFSKY PERFORMANCE STATUS IN ESTIMATING LIFE-SPAN OF TERMINALLY ILL CANCER-PATIENTS
Authors: MALTONI M NANNI O DERNI S INNOCENTI MP FABBRI L RIVA N MALTONI R AMADORI D
Citation: M. Maltoni et al., CLINICAL-PREDICTION OF SURVIVAL IS MORE ACCURATE THAN THE KARNOFSKY PERFORMANCE STATUS IN ESTIMATING LIFE-SPAN OF TERMINALLY ILL CANCER-PATIENTS, European journal of cancer, 30A(6), 1994, pp. 764-766
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY
Authors: DEANGELIS V BALLATORI E ROILA F TONATO M DELFAVERO A BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVALLI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: V. Deangelis et al., ON THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PATIENTS UNDERGOING CHEMOTHERAPY, Supportive care in cancer, 2(3), 1994, pp. 171-176
RANDOMIZED TRIAL OF EPIRUBICIN VERSUS FLUOROURACIL IN ADVANCED GASTRIC-CANCER - AN INTERNATIONAL-COLLABORATIVE-CANCER-GROUP (ICCG) STUDY
Authors: COOMBES RC CHILVERS CED AMADORI D MEDI F FOUNTZILAS G RAUSCHECKER H VASSILOPOULOS P FERREIRA EP VANNOZZI G BLISS JM WOODS E WILS J
Citation: Rc. Coombes et al., RANDOMIZED TRIAL OF EPIRUBICIN VERSUS FLUOROURACIL IN ADVANCED GASTRIC-CANCER - AN INTERNATIONAL-COLLABORATIVE-CANCER-GROUP (ICCG) STUDY, Annals of oncology, 5(1), 1994, pp. 33-36
A CLASS OF HYPERBOLIC OPERATORS WITH DOUBLE CHARACTERISTICS
Authors: AMADORI D PARENTI C
Citation: D. Amadori et C. Parenti, A CLASS OF HYPERBOLIC OPERATORS WITH DOUBLE CHARACTERISTICS, Communications in partial differential equations, 19(7-8), 1994, pp. 1185-1201
EAP IN ADVANCED GASTRIC-CANCER
Authors: RIDOLFI R GIUNCHI DC AMADORI M INNOCENTI MP MALTONI R AMADORI D
Citation: R. Ridolfi et al., EAP IN ADVANCED GASTRIC-CANCER, European journal of cancer, 29A(8), 1993, pp. 1219-1220
MYELOPROTECTIVE EFFECT OF MEDROXYPROGESTERONE ACETATE (MPA)
Authors: AMADORI D
Citation: D. Amadori, MYELOPROTECTIVE EFFECT OF MEDROXYPROGESTERONE ACETATE (MPA), European journal of cancer, 29A(7), 1993, pp. 1073-1074
PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER
Authors: BAJETTA E COLLEONI M ROSSO R SOBRERO A AMADORI D COMELLA G MARANGOLO M SCANNI A LORUSSO V CALABRESI F BONSIGNORI M CRIVELLARI D PASQUINI E BRUZZI P REPETTO M CRISCUOLO D
Citation: E. Bajetta et al., PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 29A(12), 1993, pp. 1658-1663
DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY
Authors: ROILA F DELFAVARO A BALLATORI E OLIVIERI A TONATO M DEANGLIS V BASURTO C BRACARDA S CORGNA E PICCIAFUOCO M PATOIA L FAVAUI G GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R FEDERICO M MATERA G CELLERINO R DAZZI C MARANGGLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: F. Roila et al., DIFFERENCE IN PERSISTENCE OF EFFICACY OF 2 ANTIEMETIC REGIMENS ON ACUTE EMESIS DURING CISPLATIN CHEMOTHERAPY, Journal of clinical oncology, 11(12), 1993, pp. 2396-2404
GM-CSF PRODUCTION IN HUMAN ADENOCARCINOMA CELL-LINES
Authors: MONTI F SZYMCZUK S MOTTA MR BENINI C FATTORI PP PINI E PASQUINI E ZOLI W AMADORI D RAVAIOLI A
Citation: F. Monti et al., GM-CSF PRODUCTION IN HUMAN ADENOCARCINOMA CELL-LINES, Journal of biological regulators and homeostatic agents, 7(3), 1993, pp. 85-91
ITERATIVE USE OF A PRIORI EXPOSURE MATRICES TO IMPROVE THE CHARACTERIZATION OF CHEMICAL EXPOSURES IN AGRICULTURAL WORK STUDIES
Authors: NANNI O RICCI M LUGARESI C AMADORI D FALCINI F BUIATTI E
Citation: O. Nanni et al., ITERATIVE USE OF A PRIORI EXPOSURE MATRICES TO IMPROVE THE CHARACTERIZATION OF CHEMICAL EXPOSURES IN AGRICULTURAL WORK STUDIES, Scandinavian journal of work, environment & health, 19(3), 1993, pp. 191-199
LOSS OF HETEROZYGOSITY AND K-RAS GENE-MUTATIONS IN GASTRIC-CANCER
Authors: RANZANI GN RENAULT B PELLEGATA NS FATTORINI P MAGNI E BACCI F AMADORI D
Citation: Gn. Ranzani et al., LOSS OF HETEROZYGOSITY AND K-RAS GENE-MUTATIONS IN GASTRIC-CANCER, Human genetics, 92(3), 1993, pp. 244-249
ESTABLISHMENT AND CHARACTERIZATION OF A NEW CELL-LINE FROM PRIMARY HUMAN BREAST-CARCINOMA
Authors: AMADORI D BERTONI L FLAMIGNI A SAVINI S DEGIOVANNI C CASANOVA S DEPAOLA F AMADORI A GIULOTTO E ZOLI W
Citation: D. Amadori et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW CELL-LINE FROM PRIMARY HUMAN BREAST-CARCINOMA, Breast cancer research and treatment, 28(3), 1993, pp. 251-260
QUANTITATIVE IMMUNOHISTOCHEMICAL DETERMINATION OF CATHEPSIN-D AND ITSRELATION WITH OTHER VARIABLES
Authors: VENERONI S DAIDONE MG DIFRONZO G CAPPELLETTI V AMADORI D RICCOBON A PARADISO A CORREALE M SILVESTRINI R
Citation: S. Veneroni et al., QUANTITATIVE IMMUNOHISTOCHEMICAL DETERMINATION OF CATHEPSIN-D AND ITSRELATION WITH OTHER VARIABLES, Breast cancer research and treatment, 26(1), 1993, pp. 7-13
BASE TRANSITIONS ARE THE MOST FREQUENT GENETIC CHANGES AT P53 IN GASTRIC-CANCER
Authors: RENAULT B VANDENBROEK M FODDE R WIJNEN J PELLEGATA NS AMADORI D KHAN PM RANZANI GN
Citation: B. Renault et al., BASE TRANSITIONS ARE THE MOST FREQUENT GENETIC CHANGES AT P53 IN GASTRIC-CANCER, Cancer research, 53(11), 1993, pp. 2614-2617
Risultati: 1-25 | 26-50 | 51-66 |